LIM
ORGO icon

Longfellow Investment Management’s Organogenesis Holdings ORGO Stock Holding History

Longfellow Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-302,316
Closed -$3.02M – 102
2018
Q1 		$3.02M Buy
302,316
+500
+0.2% +$4.98K 0.65% 52
2017
Q4 		$2.99M Sell
301,816
-125,769
-29% -$1.25M 0.73% 48
2017
Q3 		$4.28M Sell
427,585
-279,980
-40% -$2.78M 1.15% 34
2017
Q2 		$6.97M Buy
707,565
+339,876
+92% +$3.34M 2% 20
2017
Q1 		$3.63M Buy
+367,689
New +$3.63M 1.39% 23

Other funds holding ORGO

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Longfellow Investment Management's ORGO Position: Q2 2018 in Review

Longfellow Investment Management sold out of Organogenesis Holdings (ORGO) in Q2 2018, closing a stake of 302,316 shares — an estimated $3.02M sold.

Longfellow Investment Management first reported a position in ORGO in Q1 2017 and held it in 5 quarters. The position peaked at $6.97M in Q2 2017. 34 funds tracked by Wall St. Rank hold ORGO as of Q2 2018.

  • Longfellow Investment Management reported no remaining Organogenesis Holdings position as of Q2 2018 after selling out during the quarter.
  • Longfellow Investment Management sold 302,316 Organogenesis Holdings shares in Q2 2018, an estimated $3.02M.
  • Longfellow Investment Management first reported a position in Organogenesis Holdings in Q1 2017 and held it in 5 quarters.
  • Longfellow Investment Management's Organogenesis Holdings position peaked at $6.97M in Q2 2017.
  • 34 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2018.

Based on Longfellow Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.